Utilizing the Lung as a Model to Study Nanoparticle-Based Drug Delivery Systems.

Area of Science:

• Pharmacology
• Nanotechnology
• Respiratory Medicine

Background:

• Intranasal administration is a preferred route for drug delivery to the lungs, but drug stability and controlled release remain challenges.
• Nanoparticles have emerged as advanced therapeutic delivery vehicles and bioimaging tools over the last 30 years.
• Mouse models are crucial for evaluating drug delivery and biodistribution strategies in physiologically relevant conditions.

Purpose of the Study:

• To describe a mouse model for nanoparticle administration to the lungs via intranasal delivery.
• To present techniques for evaluating nanoparticle uptake, biodistribution, and immune response.
• To provide a versatile protocol applicable to various nanoparticle-based drug delivery systems targeting the respiratory tract.

Main Methods:

• Utilized intranasal administration in a mouse model for nanoparticle delivery to the lungs.
• Employed techniques to assess nanoparticle uptake, biodistribution, and associated immune responses.
• Optimized protocols for fluorescently labeled nanoparticles, adaptable to other delivery systems.

Main Results:

• Established a functional model for intranasal nanoparticle delivery to the lungs.
• Demonstrated methods for evaluating nanoparticle behavior and host response in vivo.
• Validated the adaptability of the protocol for diverse nanoparticle formulations and drug delivery systems.

Conclusions:

• Intranasal nanoparticle delivery presents a viable strategy to overcome challenges in lung drug delivery.
• The described mouse model and evaluation techniques are valuable for advancing respiratory therapeutics.
• This research provides a framework for studying nanoparticle-based treatments for airway and lung diseases.